CUSIP 48669G303SPONSORED ADSKZIAQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
22 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Alyeska Investment Group, L.P. | 738.3K | $5.09M | +738.3K | New |
| 2 | Stonepine Capital Management, LLC | 460.4K | $3.17M | +460.4K | New |
| 3 | Bleichroeder LP | 400.0K | $2.76M | +400.0K | New |
| 4 | Velan Capital Investment Management LP | 300.0K | $2.07M |
| +300.0K |
| New |
| 5 | Point72 Asset Management, L.P. | 200.0K | $1.38M | +200.0K | New |
| 6 | Empery Asset Management, LP | 170.0K | $1.17M | +170.0K | New Position |
| 7 | Corsair Capital Management, L.P. | 70.0K | $470.2K | +70.0K | New |
| 8 | Royal Bank Of Canada | 54.1K | $373.0K | +54.1K | New |
| 9 | Westside Investment Management, Inc. | 30.9K | $212.7K | +30.9K | New |
| 10 | Barclays PLC | 24.0K | $165.4K | −1 | Reduced |
See every fund holding Kazia Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders